UNIverse - Public Research Portal
Project cover

Implementation of liquid biopsies during routine clinical care in patients with advanced malignancies (LIQPLAT)

Research Project
 | 

This is a trial using routinely collected health care data from an ongoing registry (AO_2023- 00091) in cancer patients with advanced solid malignancies receiving first line systemic anti- cancer treatment for advanced disease.

This trial will assess the feasibility and implementation of routine measurement of ctDNA and its association with clinical outcomes, including quality of life and survival. All patients will receive routine diagnostics, treatment and follow-up. All patients with a new cancer diagnosis will be assessed for eligibility based on the routinely collected information available in the registry. We will then randomly decide which eligible patients are invited to participate in the trial. If patients accept the invitation and intend to get a measurement of ctDNA, they have to provide written informed consent.

The feasibility target sample size is 150 patients who accepted the invitation. We have chosen to randomly invite patients to participate, because: first, current capacities are not sufficient to offer regular ctDNA measurement to all cancer patients; second, we aim to recruit an unbiased and representative sample of patients; third, we aim to conduct comparative analyses with high internal and external validity so that our results are directly and reliably transferable to a large group of future cancer patients. 

Members (10)

Profile Photo

Mascha Binder

Profile Photo

Lars G. Hemkens

FEMALE avatar

Perrine Janiaud

Profile Photo

Benjamin Kasenda

Owner
MALE avatar

Heinz Läubli

MALE avatar

Matthias Matter

Show more